COPPER KING MINING (OTC: CPRK)
"Up 27.27% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/CPRK.php

Copper King Mining Corporation currently owns approximately 1200 acres in the Drum Mountains of Utah, which are patent deeded mining claims which contain gold, silver and copper. The company recently added to its holdings by filing six more claims on land which was inside their holdings, but not patent deeded. Contiguous to that acreage is approximately 1100 acres of claims filed by Western Utah Copper Company. As the companies explored the concept of a joint venture on the Drum Mountain properties, it was decided that a very viable consideration was to join the total assets of both companies.

CPRK News:

March 3 - Copper King Mining Corporation Gets Massive Coverage in LA County and Utah

Copper King Mining Corporation (OTC: CPRK), under the direction of its PR Firm Alexander Lindale L.L.C., has installed 55 full-sized billboards in LA County with 24 to follow in Utah. The billboards invite people to come and view the website for Copper King.

In conjunction with the billboards, there will be the release of a several-minute video news release on Copper King Mining that will be sent to several thousand TV stations via satellite uplink, and several thousand radio talk shows, newspapers and trade magazines. The purpose of the advertising blitz is to bring public awareness to Copper King Mining, a major employer in Milford, Utah, and provide an educational experience in the history and development of copper in the United States.

For additional information, visit www.copperkingmining.com.

AMELOT HOLDINGS INCORPORATED (OTC: AMHD)
"Up 100.00% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/AMHD.php

Amelot Holdings, Inc. (www.amelotholdings.com) is a publicly-traded diversified holding company that has identified a projected $20 billion opportunity to manufacture renewable fuels to supply the growing demand and to reduce the dependency and environmental impact of fossil fuels.

AMHD News:

March 4 - Amelot Announces Formation of Jatropha Biofuel Technologies Inc.

Amelot Holdings, Inc. (OTC: AMHD) announced the formation of its new subsidiary, Jatropha Biofuel Technologies, Inc. (“JBTI”). The subsidiary will offer a truly integrated approach, which will include all aspects of Jatropha research, development, and cultivation, including extracting technologies of Jatropha oils and the processing of high grade biodiesel.

Jatropha is an oil-rich, non-edible plant that grows on wastelands and is a promising alternative energy feedstock for the production of biodiesel. Through intensive research, JBTI will concentrate on harnessing the potential of high yield Jatropha species. More information on Jatropha can be found at:

www.thewoodexplorer.com/maindata/we1654.html.

“Jatropha has recently become an agricultural and economic celebrity, with the discovery that it may be the ideal biofuel crop, an alternative to fossil fuels for a world dangerously dependent on oil supplies and deeply alarmed by the effects of global warming,” commented Aziz Hirji, President of Amelot Holdings, Inc.

WORLD AM INCORPORATED (OTCBB: WDAM)
"Up 50.00% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/WDAM.php

World Am, Inc. engages in the development, manufacture, and distribution of automatic passage control (APC) and security devices; and marketing technologies in the field of micro-sensor elements and sensor arrays in the United States. Its products are used to monitor or control access, egress, or passage from one area to another, such as airport security portals, building entries and exits, gates for vehicles or personnel, public building access points, laboratories, hospitals, and government and other buildings. The company also involves in the design and manufacture of a standard line of APC systems for commercial, retail, and government use; customization/modification of APC systems per customer specifications; development of security devices for APC; and acquisition, development, sales, marketing, and distribution of component products. World Am sells its products through a dealer network or directly to the end user. The company was founded in 2005 and is headquartered in Newport Beach, California.

WDAM News:

March 4 - World Am's Isotec Subsidiary and Checkpoint Systems' Security Group Sign Product Distributorship Agreement Covering 10 Southeastern States

New Pact Expands Isotec's Total Distributorships Nearly 50 Percent, Now 31 Worldwide

Isotec, Inc., a subsidiary of World Am, Inc. (OTCBB: WDAM) reported that it has signed a distributorship agreement covering 10 Southeastern states with Checkpoint Systems, Inc.'s (NYSE: CKP) subsidiary, Checkpoint Security Systems Group, Inc. Checkpoint Systems, with annual revenues of approximately $700 million, is a leading manufacturer and marketer of identification, tracking, security and merchandising solutions for the retail industry and its supply chain.

Under terms of the agreement, which immediately increases Isotec's distributor presence by nearly 50%, for a current total of 31 distribution points worldwide, Checkpoint Security Systems will begin marketing Isotec's automated security portals in its already established distributorships in Delaware, Maryland, the District of Columbia, Virginia, North Carolina, South Carolina, Alabama, Mississippi and Florida.

“This is an especially big win, and validation, for our company and its technology,” said Isotec President Ken Jochim. “It's not every day you can grow your distributorship potential by half with one new agreement. Moreover,” Jochim noted, “we hope to further increase that penetration, as Checkpoint Security's mission is to grow its marketplace to a nationwide level over the next several years.”

At Checkpoint Systems, Mr. Jochim noted, strategic safety, security and loss prevention programs combine the best of several technologies to help reduce losses from internal and external theft, vandalism, and many other causes.

“Checkpoint's custom-designed systems give retail banking customers the option to arm a perimeter, a stockroom, or a whole facility — whether protecting a single storefront or a national chain. It also can provide specialized products and applications, including perimeter protection, exterior, time-delayed alarms, and access monitoring. That is precisely why we're so pleased to have the superior features of our product line now included in Checkpoint's offerings,” the Isotec president said.

ABOUT CHECKPOINT SYSTEMS, INC.

Checkpoint Systems is the leading supplier of shrink management solutions. Checkpoint's global team partners with retailers and their suppliers to fight the $98 billion global retail theft challenge. Leveraging its 40 years of RF technology expertise, expanding shrink management offerings and Check-Net labeling solutions, Checkpoint today has more than one million RF devices installed in stores around the world.

STEN CORPORATION (NASD: STEN)
"Up 44.24% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/STEN.php

STEN Corporation principally provides financial services in the United States. It provides auto loans to consumers under installment receivable contracts, as well as finances a portion of the dealer-partner vehicle inventory. The company also provides short term consumer loans, such as auto title loans and deferred presentment loans, check cashing, bill payment options, and money wires. In addition, STEN engages in the retail of used cars. Further, it manufactures, on a contract basis, a line of sterilization containers and filters for use by hospitals, clinics, and surgery centers. The company was founded in 1978. It was formerly known as Oxboro Medical International, Inc. and subsequently changed its name to Sterion Incorporated. It further changed its name to STEN Corporation in 2005. The company is headquartered in Minnetonka, Minnesota.

STEN News:

March 3 - STEN Corporation Sees Second Quarter Revenue Increasing More Than 100 Percent - Company Sees Improving Profit Outlook

STEN Corporation (NASD: STEN), a Minneapolis-based diversified business, announced that based upon results through February 2008, revenue for the second quarter ending March 31, 2008 is expected to exceed $4.2 million, more than double the $2.1 million in revenue in the Company generated in the first quarter of fiscal 2008. The Company also stated that it expects to be profitable in the current quarter. For the fiscal year ending September 30, 2008, the Company's outlook is for total revenue to exceed $15.0 million, which is more than triple last year's total revenue from continuing operations of $4.6 million. The Company's business plan currently indicates that it will operate profitably for the balance of the fiscal year ending September 30, 2008. The preliminary results for the first quarter 2008 are subject to the Company's management and independent auditors' customary quarterly review procedures. The Company will report final results of operations for the thirteen weeks ending March 31, 2008 with the filing of its Quarterly Report on 10-QSB.

Commenting on the current outlook for STEN Corporation, Kenneth Brimmer, CEO, noted, "In February we saw positive results from our efforts to achieve profitability. Among the recent steps toward improved results is the January 2008 hiring of John Halvorsen as COO of STEN Credit. Mr. Halvorsen oversees the Arizona auto sales and credit operations. John's leadership and extensive automobile sales experience have had an immediate and significant positive impact on our results. In addition, as we noted at the end of our first quarter, activity at our STENCOR business unit is increasing and improved production volumes are favorably impacting our results."

PLATINA ENERGY GROUP (OTCBB: PLTG)
"Up 30.77% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/PLTG.php

Platina Energy Group, Inc., an exploration stage company, engages in the exploration and development of oil and gas properties. It owns interests in the Hall and Kirkpatrick leases in the Palo Duro Basin located in Swisher and Hale County; and oil and gas leases located in Young County in Texas. The company also owns interests in various oil and gas leases in the Devonian Black Shale formation located in the Appalachian Basin of east Tennessee. In addition, Platina Energy Group owns certain rights in Thermal Pulse Unit (TPU), a proprietary enhanced oil recovery technology that utilizes a hydraulic gas compressor to enhance the production of mature oil fields and stripper wells. The TPU creates 350F+ heat and 1,500+psi pressures for utilization in well cleanup, stimulation, and production. The company was incorporated in 1988 as Windom, Inc. and after undergoing various business changes, the company's name was changed to Platina Energy Group, Inc. in 2005. Platina Energy Group is headquartered in Cheyenne, Wyoming.

PLTG News:

March 4 - Platina Energy Group Reports 22 Barrels Production in Three Hours for First Stout Well

Platina Energy Group, Inc. (OTCBB: PLTG) (Frankfurt: O5Y.F) reports production of 22 barrels of high grade oil in the first three hours of production for the initial "Stout" Well rework program on the Seminole County, Oklahoma Lease. This is the first of 10 wells to be reworked by Platina's on site operating division, Bowie Energy.

"The Seminole County Lease in Oklahoma is a relatively new acquisition by Platina that was previously reported. The Company had secured first lien holder financing last year to begin the reworking of this field that has already exceeded previous expectations. Although the initial production was very high, we believe that this oil well should average 150-300 BOPM henceforth, giving us a very attractive return on capital deployed. Local management has been very aggressive in preparing and scheduling the rework program for the field and we are expecting great things from here," stated Blair Merriam, President of Platina Energy Group.

PANACOS PHARMACEUTICALS INCORPORATED (NASD: PANC)
"Up 1.47% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/PANC.php

Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat Human Immunodeficiency Virus (HIV) and other human viral diseases. Its lead product candidate, bevirimat, under Phase 2 clinical trials, is a class of drug candidates that works by a novel mechanism of action called maturation inhibition. The company's discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. It also has research and development programs designed to generate second and third-generation maturation inhibition products; and a research and development program focused on an early step in the HIV virus life cycle, fusion of the HIV virus to human cells. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.

PANC News:

March 4 - Panacos Reports Fourth Quarter and Full Year 2007 Results

Panacos Pharmaceuticals, Inc. (NASD: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, announced its financial results for the quarter and year ended December 31, 2007 and reviewed progress in its development programs.

“We have accomplished a great deal in the past several months,” said Dr. Alan W. Dunton, Panacos’ President and Chief Executive Officer. “In addition to wrapping up our dose escalation of bevirimat, we have successfully determined the means to identify patients who are likely to respond to bevirimat, which will help in future studies of our lead compound and will fit into practice patterns for HIV physicians. Additionally, we have selected a lead compound in our first-in class oral HIV fusion inhibitor program. On the corporate front, we are confident we now have the right team of people in place to see bevirimat through to commercialization.”

Financial Highlights:

1) For the fourth quarter of 2007, Panacos reported a net loss of $9.3 million or $0.17 per share versus a net loss of $8.7 million or $0.17 per share for the fourth quarter of 2006. Revenue from research funding in the fourth quarter of 2007 decreased to $22,000 from $25,000 for the fourth quarter of 2006. Net loss for the 12 months ended December 31, 2007 was $37.5 million or $0.70 per share, compared to $38.1 million, or $0.75 per share for the 12 months ended December 31, 2006.

2) Research and development expenses in the fourth quarter of 2007 decreased to $6.2 million from $6.6 million in the fourth quarter of 2006, primarily as a result of decreased activity in the Company’s development programs. Research and development expenses increased slightly for the full year 2007 to $25.1 million compared to $24.5 million for the full year 2006. General and administrative expenses in the fourth quarter of 2007 increased slightly to $3.1 million from $3.0 million in the fourth quarter of 2006. General and administrative expenses decreased for the full year 2007 to $12.8 million from $17.4 million for the full year 2006.

3) Unrestricted cash, cash equivalents and marketable securities were $51.9 million at December 31, 2007. As of December 31, 2007 the Company had approximately 53.5 million common shares outstanding.

Recent Business Highlights:

Earlier today, the Company announced that it has discovered certain factors that predict response to bevirimat, its lead HIV maturation inhibitor. The Company has completed its dose-ranging study of five treatment-experienced patient cohorts with doses ranging up to 400 mg daily and provided preliminary analysis of the completed study results. Patients who had the predictors of response and effective bevirimat target blood levels had a mean viral load reduction of 1.26 log10. Patients who are most likely to respond to bevirimat treatment can be assessed with a simple, rapid, and inexpensive test that fits into existing clinical practice. The active dose range and plasma concentrations required for optimal response to bevirimat have been determined and are achievable using existing solid or liquid formulations. Clinically, bevirimat’s adverse event profile was indistinguishable from placebo across all doses in the study.

The Company has recently selected a lead compound in its oral HIV fusion inhibitor program. Panacos plans to move this compound, PA-161, forward into pre-clinical safety testing prior to potential evaluation in human clinical studies.

The Company announced the appointment of Jane Pritchett Henderson as Chief Financial and Business Officer. Ms. Henderson has over 19 years of experience in finance for health care companies, having completed deals and engagements for more than 90 life-sciences companies. Before joining Panacos, Ms. Henderson was a Managing Director at HSBC's investment banking division covering biotechnology companies, where she was responsible for global origination and execution of biopharmaceutical business on a new investment banking platform. Prior to HSBC, Ms. Henderson was with CIBC World Markets, where she was a Managing Director in the health care group. Earlier in her career, she held senior positions in healthcare investment banking at Lehman Brothers and Salomon Smith Barney (Citigroup).

Panacos held a conference call on Tuesday, March 4, to discuss the fourth quarter and full year results and the Company's development programs. The conference call can be accessed via the web at www.panacos.com through April 3, 2008, or by dialing toll-free 888.286.8010, and outside the U.S. 617.801.6888 with passcode 99073711.